Document is current
Any future updates will be listed below
-
Authors
Lee, Kyoo-Hyung https://orcid.org/0000-0002-2841-0779
Yoon, Suk Ran
Gong, Jeong-Ryeol https://orcid.org/0000-0001-7057-4489
Choi, Eun-Ji https://orcid.org/0000-0002-9568-8877
Kim, Hun Sik
Park, Chan-Jeoung
Yun, Sung-Cheol
Park, Soo-Yeon
Jung, Sol-Ji
Kim, Hanna
Lee, Soo Yun
Jung, Haiyoung
Byun, Jae-Eun
Kim, Mirang https://orcid.org/0000-0001-7415-0077
Kim, Seon-Young https://orcid.org/0000-0002-1030-7730
Kim, Jeong-Hwan
Lee, Je-Hwan https://orcid.org/0000-0002-7060-1675
Lee, Jung-Hee
Choi, Yunsuk
Park, Han-Seung
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Woo, Jimin
Kang, Hyeran
Baek, Seunghyun
Kim, Su Mi
Kim, Hoon-Min
Cho, Kwang-Hyun https://orcid.org/0000-0002-7380-7142
Choi, Inpyo
- License Information
-
More Information
Article History
Received: 21 October 2022
Revised: 29 January 2023
Accepted: 9 February 2023
First Online: 17 March 2023
Competing interests
: K-HL, E-JC, J-HL, J-HL, and H-SP are recipients of royalty from Ingenium Therapeutics, Daejon, Korea. K-HL and E-JC are consultants for the same company and receive consultation fees. The other authors declare no competing conflict of interest.
